MARKET NEWS AND UPDATES.
Get notified for Latest News and Market Alerts.
Get notified for Latest News and Market Alerts.
×
CMP as on 23-May-22 15:30
₹ 408.30Open
₹ 421.50Turnover (lac)
₹ 450Prev. Close
₹ 421.55Day's Vol (shares)
₹ 1,10,163CMP as on23-May-22 15:29
₹ 412.40Open
₹ 421.10Turnover (lac)
₹ 71Prev. Close
₹ 421.45Day's Vol (shares)
₹ 1,603Sales rise 63.73% to Rs 340.60 crore
On 23 May 2022
With four observations
The Company will be submitting the responses to USFDA observations within stipulated timeline and implement the corrective actions to a
Biosimilar Aflibercept is the second biosimilar product from SML that has entered the clinical trial phase after Biosimilar Adalimumab.
The rating on fund-based working capital limits has been affirmed at IND A+/Stable/IND A1.
Sales rise 42.38% to Rs 272.30 crore
On 8 February 2022
The product will be manufactured, for EU commercialization at its own EU GMP compliant, injectable manufacturing facility situated in T
Shilpa Medicare launches PRUCALSHIL (Prucalopride) Orally Disintegrating Strips in India
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity
